FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3133622644> ?p ?o ?g. }

• W3133622644 endingPage "388" @default.
• W3133622644 startingPage "379" @default.
• W3133622644 abstract "As a partner antimalarial with an extremely long elimination half-life (∼30 days), piperaquine (PQ) is mainly metabolized into a pharmacologically active N-oxide metabolite [piperaquine N-oxide (PN1)] in humans. In the present work, the metabolic retroversion of PQ and PN1, potentially associated with decreased clearance of PQ, was studied. The results showed that interconversion existed for PQ and its metabolite PN1. The N-oxidation of PQ to PN1 was mainly mediated by CYP3A4, and PN1 can rapidly reduce back to PQ via cytochrome P450 (P450)/flavin-containing monooxygenase enzymes. In accordance with these findings, the P450 nonselective inhibitor (1-ABT) or CYP3A4 inhibitor (ketoconazole) inhibited the N-oxidation pathway in liver microsomes (>90%), and the reduction metabolism was inhibited by 1-ABT (>90%) or methimazole (∼50%). Based on in vitro physiologic and enzyme kinetic studies, quantitative prediction of hepatic clearance (CLH) of PQ was performed, which indicated its negligible decreased elimination in humans in the presence of futile cycling, with the unbound CLH decreasing by 2.5% (0.069 l/h per kilogram); however, a minor decrease in unbound CLH (by 12.8%) was found in mice (0.024 l/h per kilogram). After an oral dose of PQ (or PN1) to mice, the parent form predominated in the blood circulation, and PN1 (or PQ) was detected as a major metabolite. Other factors probably associated with delayed elimination of PQ (intestinal metabolism and enterohepatic circulation) did not play a key role in PQ elimination. These data suggested that the metabolic interconversion of PQ and its N-oxide metabolite contributes to but may not significantly prolong its duration in humans. SIGNIFICANCE STATEMENT: This paper investigated the interconversion metabolism of piperaquine (PQ) and its N-oxide metabolite in vitro as well as in mice. The metabolic profiles of PQ were reestablished by this futile cycling, which contributes to but may not significantly prolong its elimination in humans. Enzyme phenotyping indicated a low possibility of interaction of PQ during artemisinin drug-based combination therapy treatment." @default.
• W3133622644 created "2021-03-15" @default.
• W3133622644 creator A5009310956 @default.
• W3133622644 creator A5018659686 @default.
• W3133622644 creator A5020413501 @default.
• W3133622644 creator A5052147786 @default.
• W3133622644 date "2021-03-05" @default.
• W3133622644 modified "2023-10-16" @default.
• W3133622644 title "Metabolic Retroversion of Piperaquine (PQ) via Hepatic Cytochrome P450–Mediated <i>N</i>-Oxidation and Reduction: Not an Important Contributor to the Prolonged Elimination of PQ" @default.
• W3133622644 cites W1484050965 @default.
• W3133622644 cites W1593954768 @default.
• W3133622644 cites W1973433182 @default.
• W3133622644 cites W1977609703 @default.
• W3133622644 cites W1985984753 @default.
• W3133622644 cites W1988858173 @default.
• W3133622644 cites W1994627863 @default.
• W3133622644 cites W2000037033 @default.
• W3133622644 cites W2002814172 @default.
• W3133622644 cites W2005123904 @default.
• W3133622644 cites W2013135431 @default.
• W3133622644 cites W2015640172 @default.
• W3133622644 cites W2033656860 @default.
• W3133622644 cites W2043263657 @default.
• W3133622644 cites W2048716336 @default.
• W3133622644 cites W2064949809 @default.
• W3133622644 cites W2076336531 @default.
• W3133622644 cites W2080787906 @default.
• W3133622644 cites W2092759716 @default.
• W3133622644 cites W2093113482 @default.
• W3133622644 cites W2094792978 @default.
• W3133622644 cites W2106515170 @default.
• W3133622644 cites W2118198130 @default.
• W3133622644 cites W2120895068 @default.
• W3133622644 cites W2130449545 @default.
• W3133622644 cites W2143432220 @default.
• W3133622644 cites W2163860077 @default.
• W3133622644 cites W2169329132 @default.
• W3133622644 cites W2179033068 @default.
• W3133622644 cites W2322012164 @default.
• W3133622644 cites W2337432586 @default.
• W3133622644 cites W2467485523 @default.
• W3133622644 cites W2492616822 @default.
• W3133622644 cites W2783193238 @default.
• W3133622644 cites W2804175122 @default.
• W3133622644 cites W2806321658 @default.
• W3133622644 cites W2934688564 @default.
• W3133622644 cites W2967216925 @default.
• W3133622644 cites W2981993520 @default.
• W3133622644 cites W3011147288 @default.
• W3133622644 cites W4249794376 @default.
• W3133622644 doi "https://doi.org/10.1124/dmd.120.000306" @default.
• W3133622644 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33674271" @default.
• W3133622644 hasPublicationYear "2021" @default.
• W3133622644 type Work @default.
• W3133622644 sameAs 3133622644 @default.
• W3133622644 citedByCount "2" @default.
• W3133622644 countsByYear W31336226442022 @default.
• W3133622644 countsByYear W31336226442023 @default.
• W3133622644 crossrefType "journal-article" @default.
• W3133622644 hasAuthorship W3133622644A5009310956 @default.
• W3133622644 hasAuthorship W3133622644A5018659686 @default.
• W3133622644 hasAuthorship W3133622644A5020413501 @default.
• W3133622644 hasAuthorship W3133622644A5052147786 @default.
• W3133622644 hasBestOaLocation W31336226441 @default.
• W3133622644 hasConcept C109650736 @default.
• W3133622644 hasConcept C112705442 @default.
• W3133622644 hasConcept C13002179 @default.
• W3133622644 hasConcept C185592680 @default.
• W3133622644 hasConcept C192989942 @default.
• W3133622644 hasConcept C2777477808 @default.
• W3133622644 hasConcept C2778620825 @default.
• W3133622644 hasConcept C526171541 @default.
• W3133622644 hasConcept C55493867 @default.
• W3133622644 hasConcept C62231903 @default.
• W3133622644 hasConcept C86803240 @default.
• W3133622644 hasConcept C89311334 @default.
• W3133622644 hasConcept C98274493 @default.
• W3133622644 hasConceptScore W3133622644C109650736 @default.
• W3133622644 hasConceptScore W3133622644C112705442 @default.
• W3133622644 hasConceptScore W3133622644C13002179 @default.
• W3133622644 hasConceptScore W3133622644C185592680 @default.
• W3133622644 hasConceptScore W3133622644C192989942 @default.
• W3133622644 hasConceptScore W3133622644C2777477808 @default.
• W3133622644 hasConceptScore W3133622644C2778620825 @default.
• W3133622644 hasConceptScore W3133622644C526171541 @default.
• W3133622644 hasConceptScore W3133622644C55493867 @default.
• W3133622644 hasConceptScore W3133622644C62231903 @default.
• W3133622644 hasConceptScore W3133622644C86803240 @default.
• W3133622644 hasConceptScore W3133622644C89311334 @default.
• W3133622644 hasConceptScore W3133622644C98274493 @default.
• W3133622644 hasIssue "5" @default.
• W3133622644 hasLocation W31336226441 @default.
• W3133622644 hasLocation W31336226442 @default.
• W3133622644 hasOpenAccess W3133622644 @default.
• W3133622644 hasPrimaryLocation W31336226441 @default.
• W3133622644 hasRelatedWork W1996694250 @default.
• W3133622644 hasRelatedWork W2037012505 @default.
• W3133622644 hasRelatedWork W2063963014 @default.

• next